Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation

Abstract Recent advances have included insights into the clinical value of genomic abnormalities in acute myeloid leukemia (AML) and consequently the development of numerous targeted therapeutic agents that have improved clinical outcome. In this setting, various clinical trials have recently explor...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncology and Therapy
المؤلف الرئيسي: Xavier Thomas
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Adis, Springer Healthcare 2024-02-01
الموضوعات:
Acute myeloid leukemia
Menin inhibitors
Mutations
KMT2A
NPM1
Treatment
الوصول للمادة أونلاين:https://doi.org/10.1007/s40487-024-00262-x

الانترنت

https://doi.org/10.1007/s40487-024-00262-x

مواد مشابهة